SCHEMBL6199287

SCHEMBL6199287

CCOc1ccc(-c2nc(C(O)c3ccc(OC)c(OC)c3)cs2)cc1OCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.56
ALDH1A1 P00352 8/20 0.56
MAPT P10636 3/20 0.52
HSD17B10 Q99714 1/20 0.52
FPR2 P25090 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
GAA P10253 2/20 0.48
HPGD P15428 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
MEN1 O00255 2/20 0.44
RAB9A P51151 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
TLR7 Q9NYK1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28798317 0.76 PDE4A (0.58) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL4818551 0.75 PPARG (0.51) ALDH1A1SMN1; SMN2PDE4APDE4BPDE4C
SCHEMBL21823679 0.75 KDM4E (0.60) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL31096282 0.75 KDM4E (0.60) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL8924439 0.74 PDE4A (0.67) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL27890476 0.73 PDE4A (0.50) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL3593664 0.72 KDM4E (0.64) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL3603704 0.72 KDM4E (0.60) KDM4EALDH1A1MAPTHSD17B10FPR2
SCHEMBL11455238 0.72 KDM4E (0.63) KDM4EALDH1A1MAPTHSD17B10SMN1; SMN2
SCHEMBL13407817 0.72 KDM4E (0.59) KDM4EALDH1A1MAPTHSD17B10FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed